ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity
Structure,
Journal Year:
2024,
Volume and Issue:
32(12), P. 2244 - 2250.e3
Published: Oct. 17, 2024
Language: Английский
ATTRv-V30M Type A amyloid fibrils from the heart and nerves exhibit structural homogeneity.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 14, 2024
ATTR
amyloidosis
is
a
systemic
disease
characterized
by
the
deposition
of
amyloid
fibrils
made
transthyretin,
protein
integral
to
transporting
retinol
and
thyroid
hormones.
Transthyretin
primarily
produced
liver
circulates
in
blood
as
tetramer.
The
retinal
epithelium
also
secretes
which
secreted
vitreous
humor
eye.
Because
mutations
or
aging,
transthyretin
can
dissociate
into
amyloidogenic
monomers
triggering
fibril
formation.
myocardium
peripheral
nerves
causes
cardiomyopathies
neuropathies,
respectively.
Using
cryo-electron
microscopy,
here
we
determined
structures
extracted
from
cardiac
nerve
tissues
an
ATTRv-V30M
patient.
We
found
that
both
share
consistent
structural
conformation,
similar
previously
described
structure
individual
with
same
genotype,
but
different
obtained
humor.
Our
study
hints
uniform
fibrillar
architecture
across
within
individual,
only
when
source
liver.
Moreover,
this
provides
first
description
patient
enhances
our
understanding
role
site
production
shaping
amyloidosis.
Language: Английский
Detection of ATTR aggregates in plasma of polyneuropathic ATTR-V30M amyloidosis patients
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 13, 2024
Abstract
ATTR
amyloidosis
is
caused
by
the
deposition
of
transthyretin
amyloid
fibrils
in
tissues
often
leading
to
organ
failure
and
death.
The
clinical
spectrum
this
disease
highly
diverse
dependent
on
many
factors
including
presence
or
absence
mutations
within
protein
and/or
an
individual’s
ancestry.
phenotypic
variability
makes
it
difficult
diagnose,
delaying
treatment
worsening
patient
prognosis.
Our
lab
has
recently
developed
a
peptide
probe
that
detects
aggregates
plasma
patients
with
cardiomyopathy
but
not
been
tested
from
polyneuropathic
patients.
Here
we
evaluate
our
cohort
Portuguese
carrying
ATTR-V30M
mutation
having
no
cardiac
phenotype.
We
found
could
indeed
detect
their
plasma,
there
appeared
be
relationship
between
age
gender.
work
broad
implications
pathobiology
contribute
validation
as
novel
detection
tool
for
disease.
Language: Английский